DEBIOC: A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophago-gastric adenocarcinoma
Thomas A., VIRDEE P., Martin E., LORD S., Falk S., Anthoney DA., Turkington R., GOFF M., ELHUSSEIN L., COLLINS L., Love S., MOSCHANDREAS J., MIDDLETON M.